← BIOLIFE SOLUTIONS INC BLFS
Market Price
$35.05
Market Cap
$1.72B
P/E Ratio
N/A
Revenue (FY 2025)
↑17.0% YoY
$96.21M
3-Yr CAGR: -15.9%
Net Income
↑77.2% YoY
-$4.59M
Net Margin: -4.8%
Free Cash Flow
↑104.4% YoY
$10.64M
FCF Yield: 0.62%
EPS (Diluted)
↑77.3% YoY
$-0.10
Basic: $-0.09
Return on Equity
Efficiency
-1.2%
ROA: -48.2%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (BLFS)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2016 | $8.2M | — | $4.8M | $-6.9M | — | $-0.54 | — | $-4.3M | $-4.5M | — |
| FY 2017 | $11.0M | +34.0% | $6.7M | $-2.5M | +63.4% | $-0.21 | +61.1% | $0.6M | $0.5M | +110.3% |
| FY 2018 | $19.7M | +79.1% | $13.5M | $3.3M | +229.9% | $0.14 | +166.7% | $2.3M | $1.8M | +300.6% |
| FY 2019 | $27.4M | +38.6% | $18.6M | $-1.7M | -150.7% | $-0.09 | -164.3% | $1.2M | $0.5M | -70.9% |
| FY 2020 | $48.1M | +75.7% | $9.0M | $2.7M | +261.0% | $-0.03 | +66.7% | $6.6M | $4.7M | +770.6% |
| FY 2021 | $119.2M | +147.8% | $37.0M | $-7.6M | -386.3% | $-0.20 | -566.7% | $-4.6M | $-13.0M | -377.1% |
| FY 2022 | $161.8M | +35.8% | $53.8M | $-139.8M | -1,731.1% | $-3.29 | -1,545.0% | $-8.5M | $-18.9M | -45.4% |
| FY 2023 | $143.3M | -11.4% | $41.3M | $-66.4M | +52.5% | $-1.52 | +53.8% | $-12.5M | $-18.9M | -0.0% |
| FY 2024 | $82.3M | -42.6% | $50.1M | $-20.2M | +69.6% | $-0.44 | +71.1% | $8.4M | $5.2M | +127.6% |
| FY 2025 | $96.2M | +17.0% | $62.1M | $-4.6M | +77.2% | $-0.10 | +77.3% | $20.1M | $10.6M | +104.4% |
Valuation
Market Price
$35.05
Market Cap
$1.72B
Enterprise Value
$1.69B
P/E Ratio
N/A
P/B Ratio
4.60
FCF Yield
0.62%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
64.56%
Operating Margin
-17.26%
Net Margin
-4.78%
Return on Equity (ROE)
-1.24%
Return on Assets (ROA)
-48.24%
Asset Turnover
10.10x
Revenue 3-Yr CAGR
-15.90%
Financial Health & Liquidity
Current Ratio
1.63
Cash Ratio
5.65
Debt / Equity
0.013
Debt / Assets
0.525
Cash & Equivalents
$33.04M
Total Debt
$5.00M
Book Value / Share
$7.61
Cash Flow Efficiency
Operating Cash Flow
$20.11M
Capital Expenditures (CapEx)
$9.48M
Free Cash Flow
$10.64M
OCF / Revenue
20.91%
FCF / Revenue
11.06%
FCF 3-Yr CAGR
N/A
Per Share Metrics
EPS (Diluted)
$-0.10
EPS (Basic)
$-0.09
Dividends / Share
N/A
Book Value / Share
$7.61
EPS YoY Growth
77.27%
Balance Sheet (FY 2025)
Total Assets
$9.53M
Total Liabilities
$5.85M
Stockholders' Equity
$371.89M
Current Assets
$9.53M
Current Liabilities
$5.85M